Page Tools

 

Scientific Report


Scientific Report

Download the Scientific Report [7.5 MB]

View the entry for
David R. Schubert

 

David R. Schubert

David R. Schubert

Professor and Laboratory Head
Cellular Neurobiology Laboratory

"Our research group is studying how cells live or die in the context of Alzheimer's disease, Parkinson's disease, stroke, ischemia, and other degenerative brain disorders, with the ultimate goal of identifying drugs that inhibit cell death and getting them through the initial stages of drug development and on to the clinic."

There are currently no treatments for the nerve cell death associated with chronic neurological diseases, including Alzheimer's, Parkinson's, Huntington's, and ALS, or the neurological complications of diabetes. There are many reasons for this deficiency, but the main hurdle is the innate complexity of the diseases themselves. In most cases, the nerve cells die from several types of insults, not one specific stress or toxin. Therefore, drugs that effectively treat these conditions will have to block the different pathways that together lead to the nerve cell's demise.

Because plants lack an immune system, they instead synthesize drug-like molecules to defend themselves against infectious pathogens and insect predators. Most of these molecules have numerous biological activities, and they are the basis of much of the current pharmacopoeia. They have not, however, been exploited for the treatment of chronic neurological diseases.

Schubert's lab and that of Pamela Maher in the Cellular Neurobiology group are using a series of innovative biological assays to identify plant products that are broadly neuroprotective. They then modify the structure of the compounds through medicinal chemistry to improve their properties as drugs. The goal is to make drugs that inhibit the pathways that cause nerve cell death and are safe because they are based upon edible plant material. To date, they have identified two compounds that meet the above criteria. The first, discovered by Maher, is fisetin, found in strawberries, which is orally active in animal models of memory enhancement, Huntington's, and Parkinson's. It is also very active in a rigorous rabbit stroke model. Schubert has made potent synthetic derivatives of curcumin, the major component of the Indian spice turmeric, that work well in rabbit stroke models and memory enhancement.

Currently, this work is being extended in three areas: refinement of the chemical structures, identification of the multiple molecular targets, and testing in additional animal models where they are likely to be effective, such as the complications of diabetes and Alzheimer's. The ultimate aim is to get these compounds through the initial stages of drug development so they can be advanced to the clinic.

Lab Photo

Left to right:
Back row: Qi Chen, Richard Dargusch, Jennifer Ehren, Federico Herrera, Beatrice Fankinger Seated: Pam Maher, Dave Schubert

Print version -
David R. Schubert

Faculty

Dave R. Schubert

Dave R. Schubert

Professor and Laboratory Head
Cellular Neurobiology Laboratory

Dave R. Schubert, professor and head of the Cellular Neurobiology Laboratory, studies hormones and other substances that affect the activities and survival of brain cells. Much of his research is providing new insights into Alzheimer's disease and other degenerative brain disorders.

Schubert has been studying beta amyloid protein, a substance that accumulates in the brains of Alzheimer's patients. Schubert has shown that this protein can cause nerve cell death, while vitamin E can protect cells from its toxic effects.

A recent study conducted by scientists at UCSD showed that Vitamin E does, in fact, slow the progression of Alzheimer's. Schubert's lab also is studying the mechanisms of cell death in Parkinson's disease, stroke and ischemia, with the goal of trying to identify drugs that inhibit these processes.

Education

Awards and Honors

Salk News Releases